Employer And Workplace Drug Testing Market To Reach $9.09 Billion By 2033

Employer And Workplace Drug Testing Market Growth & Trends

The global employer and workplace Drug testing market size is expected to reach USD 9.09 billion by 2033, registering a CAGR of 4.7% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is driven by the increasing focus on maintaining a drug-free workplace to enhance productivity and reduce workplace accidents further propels demand for drug testing services.

The rising prevalence of substance abuse and its associated risks, including impaired performance and increased absenteeism, drives employers to implement comprehensive drug testing programs. Technological advancements in testing methods, such as rapid and accurate detection technologies, contribute to market growth by improving the efficiency and reliability of drug testing processes. Rising government initiative and funding programs is further driving market growth. For instance, in December 2022, the U.S. government enacted the Consolidated Appropriations Act 2023 (Public Law 117-328) (CAA 23). This legislation allocated funds to the Substance Abuse and Mental Health Services Administration (SAMHSA) for the fiscal year 2023 and included various provisions that reinforced, reauthorized, and expanded SAMHSA's programs for substance use disorders and mental health.

Many governments around the world are launching campaigns, providing funding, and establishing programs to promote awareness and prevention of substance abuse in the workplace. These initiatives often include guidelines and frameworks that encourage or mandate drug testing among employees, particularly in industries deemed high-risk. As a result, employers are increasingly adopting drug testing practices to align with government policies and benefit from incentives or funding provided for compliance with these programs.

The demand for employer and workplace drug testing products is further anticipated to increase due to the rigorous enforcement of regulations by various government agencies that mandate drug and alcohol testing for safety purposes. According to the Federal Drug-Free Workplace Program's guidelines, the SAMHSA Center for Substance Abuse Prevention oversees HHS-certified laboratories. These drug-testing programs are required for employees in sensitive roles, such as those in national security, law enforcement, and public health and safety. Both government and non-governmental organizations are implementing strategic initiatives, including new product launches, partnerships, and mergers and acquisitions, to address drug use, which contributes to the growth of the market.

Some of the key players in the market are. First Advantage; Laboratory Corporation of America Holdings (Labcorp); Drägerwerk AG & Co. KGaA; Bio-Rad Laboratories, Inc.; Abbott; Clinical Reference Laboratory Inc.; Quest Diagnostics; Cordant Health Solutions; DISA Global Solutions; HireRight, LLC; OraSure Technologies, Inc.; Omega Laboratories; Psychemedics Corporation and other are adopting key strategic initiatives such as product launches acquisition and launching patent focused resources to cater patients globally. For instance, in May 2024, eMed collaborated with i3screen to introduce a new virtual drug screening program for employers. This innovative service allows companies to conduct drug tests remotely, making the process more convenient and efficient. With this partnership, employers can now offer virtual drug screenings that are easy to administer and provide quick results, helping to streamline their hiring and compliance procedures.

 Request a free sample copy or view report summary: Employer And Workplace Drug Testing Market Report

Employer And Workplace Drug Testing Market Report Highlights

• According to a national survey by American Addiction Centers, 15.3% of U.S. workers reported working under the influence of alcohol, while 2.9% admitted to being under the influence of illicit drugs in 2024

• The post-employment segment led the employer and workplace drug testing market in 2025 with a share of 77.65%. This segment plays a vital role in safeguarding workplace safety and ensuring compliance by monitoring employees after hiring, especially in sectors such as transportation, energy, manufacturing, and healthcare

• The consumable segment led the market with the largest revenue share of 33.06% in 2025. The segment in the global market includes critical products such as urine collection cups, saliva swabs, test strips, reagents, and others

• The instant testing segment led the market with the largest revenue share of 41.31% in 2025. Employers and service providers are favoring instant tests that use saliva or oral fluid, which are less invasive than urine and provide quicker results—boosting acceptance and compliance.

• The cannabis/marijuana segment led the market with the largest revenue share of 58.72% in 2025 and is expected to grow at the fastest CAGR over the forecast period. 

• The other professional services segment led the market with the largest revenue share of 38.05% in 2025

• North America employer and workplace drug testing market dominated the global industry in 2025 with a share of 49.16%. The region’s strong position is supported by well-established regulatory frameworks, stringent workplace safety requirements, and a high level of employer adoption across industries such as transportation, construction, energy, and healthcare

Employer And Workplace Drug Testing Market Segmentation

Grand View Research has segmented the global employer and workplace drug testing market based on type, product, mode, drug, end use, and region:

Employer And Workplace Drug Testing Type Outlook (Revenue, USD Million, 2021 - 2033)

• Pre-employment drug screens

• Post-employment

Employer And Workplace Drug Testing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Consumables

• Instruments

• Rapid Testing Devices

• Services

Employer And Workplace Drug Testing Mode Outlook (Revenue, USD Million, 2021 - 2033)

• Urine

• Hair

• Oral Fluid

• Instant testing

Employer And Workplace Drug Testing Drug Outlook (Revenue, USD Million, 2021 - 2033)

• Alcohol

• Cannabis/Marijuana

• Cocaine

• Opioids

• Amphetamine & Methamphetamine

• LSD

• Others

Employer And Workplace Drug Testing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• IT/Finance

• Manufacturing

• Transportation

• Construction

• Retail and Hospitality

• Healthcare

• Education

• Other Professional Services

Employer And Workplace Drug Testing Regional Outlook (Revenue, USD Million, 2021- 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Employer And Workplace Drug Testing Market

• First Advantage

• Laboratory Corporation of America Holdings (Labcorp)

• Drägerwerk AG & Co. KGaA

• Bio-Rad Laboratories, Inc.

• Abbott

• Clinical Reference Laboratory Inc.

• Quest Diagnostics

• Cordant Health Solutions

• DISA Global Solutions

• HireRight, LLC

• OraSure Technologies, Inc.

• Omega Laboratories

• Psychemedics Corporation